Conforti, F., Merlo, F., Pala, L., Canzian, J., Tinterri, B., De Pas, T., et al. (2025). Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence. JOURNAL OF CLINICAL ONCOLOGY, 43(30), 3237-3244 [10.1200/JCO-25-01148].
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence
Merlo F.;Bagnardi V.
2025
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
